Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Annual Report
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Fees
Hotel
Venue
Helpful info
Eco-friendly info
Programme
Abstracts
Postgraduate Teaching
Nurse Programme
Hands-on
Information for Presenters
In-person Networking
myUEG Community Area
Learn from Leaders
Mentoring
The UEG Night
Let's Meet
Industry Programme
Industry Exhibition
Industry Symposia
Acknowledgements
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass on Chronic Pancreatitis
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Research
To landing page
Support
Horizon Europe Support
Research Prize
Research Fellowship
Research Webinars
Advocacy
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
Guideline development framework
Get Funding
Get Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Digestive Health Month
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Application Support
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Thomas Reiberger
Portal hypertension: Risk stratification and screening
Thomas Reiberger
CLINICAL COURSE OF FURTHER DECOMPENSATION/MORTALITY IN PATIENTS WITH CIRRHOSIS AND ASCITES AS THE FIRST SINGLE DECOMPENSATION EVENT – AN INCEPTION COHORT STUDY
LATE-STAGE PRESENTATION OF CIRRHOSIS WITH DECOMPENSATION IS ALARMINGLY COMMON AND FAVORABLE OUTCOME IS ONLY OBSERVED WITH ETIOLOGIC THERAPY
Thomas Reiberger
et al.
A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS
Thomas Reiberger
et al.
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
Thomas Reiberger
et al.
DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)
Thomas Reiberger
et al.
DISTURBANCES IN SODIUM AND CHLORIDE HOMEOSTASIS PREDICT OUTCOMES IN STABLE AND CRITICALLY ILL PATIENTS WITH CIRRHOSIS – NOT TWO SIDES OF THE SAME COIN
Thomas Reiberger
et al.
ENDOSCOPIC VARICEAL BAND LIGATION IS SAFE DESPITE LOW PLATELET COUNT AND HIGH INR
Thomas Reiberger
et al.
ACUTE HAEMODYNAMIC RESPONSE TO INTRAVENOUS PROPRANOLOL PREDICTS DECOMPENSATION AND MORTALITY IN PATIENTS WITH CIRRHOSIS
Thomas Reiberger
et al.
HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS
Thomas Reiberger
et al.
THE IMPACT OF TRANSMEMBRANE 6 SUPERFAMILY 2 (TM6SF2) RS58542926 ON LIVER-RELATED EVENTS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
Thomas Reiberger
et al.
SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
Thomas Reiberger
et al.
THE IMPACT OF PNPLA3 RS738409 RISK G ALLELES ON HEPATIC STEATOSIS, THE METABOLIC SYNDROME AND PORTAL HYPERTENSION IN ADVANCED FATTY LIVER DISEASE
Thomas Reiberger
et al.
VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE
Thomas Reiberger
et al.
PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER
Thomas Reiberger
et al.
ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS
Thomas Reiberger
et al.
SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE
Thomas Reiberger
et al.
THE ALPHA-1 ANTITRYPSIN PI*Z ALLELE INDEPENDENTLY PREDICTS LIVER TRANSPLANTATION/DEATH IN ACLD PATIENTS
Thomas Reiberger
et al.
CARVEDILOL INDUCES HIGHER HVPG RESPONSE RATES AND IS ASSOCIATED WITH LOWER RATES OF VARICEAL REBLEEDING THAN PROPRANOLOL IN SECONDARY PROPHYLAXIS OF PORTAL HYPERTENSION - A RETROSPECTIVE COHORT STUDY
Thomas Reiberger
et al.
FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
Thomas Reiberger
et al.
Item 1 - 20 / 25
1
2
Chat with us
, powered by
LiveChat